Cambodia vs Saudi Arabia: Share of people with HIV who receive antiretroviral therapy
Cambodia
92.0%
in 2024
Saudi Arabia
93.0%
in 2024
Cambodia rank
14th
Saudi Arabia rank
11th
Share of people with HIV who receive antiretroviral therapy over time
- Cambodia
- Saudi Arabia
How they compare
Saudi Arabia currently reports 93.0% against 92.0% in Cambodia, a difference of 1.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Saudi Arabia ahead.
Cambodia ranks 14th and Saudi Arabia ranks 11th of 143 countries.
Across the 3 decades both report, Cambodia averaged higher in 1 and Saudi Arabia in 2.
Head to head by decade
| Decade | Cambodia | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 15.6% | 26.1% | 10.5% | Saudi Arabia |
| 2010s | 64.6% | 57.9% | 6.7% | Cambodia |
| 2020s | 85.2% | 90.0% | 4.8% | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of people with hiv who receive antiretroviral therapy, Cambodia or Saudi Arabia?
- Saudi Arabia, at 93.0% against 92.0% in Cambodia as of 2024.
- What is the difference in share of people with hiv who receive antiretroviral therapy between Cambodia and Saudi Arabia?
- 1.0%, with Saudi Arabia ahead.
- How many years of comparable data are there for Cambodia and Saudi Arabia?
- 25 years are reported by both, from 2000 to 2024.
- How do Cambodia and Saudi Arabia rank globally for share of people with hiv who receive antiretroviral therapy?
- Cambodia ranks 14th and Saudi Arabia ranks 11th of 143 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of people with HIV who receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.